Author

admin

Browsing

It really shouldn’t be that big a deal.

Donald Trump was one of many friends solicited to send messages to Jeffrey Epstein for his 50th birthday. There’s a far more cautious one from Bill Clinton, too.

If the president had merely said ‘yeah, I sent it, we were joking back and forth, nothing to see here’ – this was in 2003, before the child predator was charged with sexual abuse – nobody would have blinked. The birthday book was assembled by his then-girlfriend Ghislaine Maxwell.

Instead, he filed a $10 billion lawsuit against the Wall Street Journal for supposedly publishing inaccuracies in its report on the Trump birthday message.

The Journal has now been vindicated.

Trump flatly denied having sent a birthday message at all. He can’t draw, he would never do such a thing, it was inconceivable.

Now it looks a lot more conceivable.

As the Journal was the first to report, there is a friendly back-and-forth against the backdrop of a sketch of a naked woman’s silhouette. Trump’s signature is in the pubic area, and the paper says it matches other acknowledged ‘Donald’ signatures – along with his use of such phrases as ‘a wonderful thing.’

There is this exchange:

Donald: We have certain things in common, Jeffrey.

Jeffrey: Yes we do, come to think of it.

Donald: Enigmas never age, have you noticed that?

Jeffrey: As a matter of fact, it was clear to me the last time I saw you.

Donald: A pal is a wonderful thing. Happy Birthday – and may every day be another wonderful secret.

That’s it, given more punch by Trump’s denial that he never sent such a thing.

In fact, after the publication of the texts and the naked silhouette – which I’m sure you’ve seen as it’s been all over television – Trump continues to deny that the letter and sketch are his. 

They’re sure doing a good job of moving on from the Epstein mess, huh?

Reached on his cell yesterday by NBC reporter Garrett Haake, Trump said: ‘I don’t comment on something that’s a dead issue. I gave all comments to the staff. It’s a dead issue.’

That sounds like wishful thinking. The only ‘dead’ part is Jeffrey Epstein.

Press Secretary Karoline Leavitt backed up the boss in a posting:

‘The latest piece published by the Wall Street Journal PROVES this entire ‘Birthday Card’ story is false. As I have said all along, it’s very clear President Trump did not draw this picture, and he did not sign it. President Trump’s legal team will continue to aggressively pursue litigation.

‘Furthermore, the ‘reporter’ @joe_palazzolo who wrote this hatchet job reached out for comment at the EXACT same minute he published his story giving us no time to respond. This is FAKE NEWS to perpetuate the Democrat Epstein Hoax!’ But it’s hardly a hoax to Epstein’s victims, who spoke out the other day – one voted for Trump – about how being lured into having sex while young as 14 ruined their lives.

The New York Times has a sobering report on other birthday messages to Epstein.

Venture capitalist William Elkus recalled Epstein conjuring a beautiful woman out of thin air during a visit to a farm town in Iowa, where it was hard to ‘tell the difference between the girls and the hogs.’ Elkus marveled at Epstein’s being able to find a ‘spectacular tall blonde’ whom he later invited back with him to New York, concluding he had relied on ‘some long distance escort service.’

Elkus told the Times that it was a joke and that he was referring to Epstein’s ‘charisma, which was palpable.’

A person named Leslie wrote, ‘I wanted to get you what you want,’ so ‘here it is’ – a drawing of breasts. Another writer sent photos of zebras, and lions, getting it on.

A person named Nick described a night in London that left Epstein ‘howling with laughter.’ Nick said an ‘old man smiling sweetly’ pulled down a woman’s panties and put his hand on her privates, only to find another man’s hand already there. 

Some women, including assistants and girlfriends – the names are redacted – may have been Epstein’s victims. 

One woman wrote: ‘With you, dear Jeffrey, I laugh like a little girl and feel like a woman.’ There’s a hand-drawn heart, a brief message and a photo of a woman’s butt in a thong bikini.

There’s a cartoon of Epstein in a beach chair getting ‘what appears to be a nude massage from four topless women.’ Appears? That’s exactly what it is.

There were messages from Nathan Myhrvold, former chief technology officer for Microsoft; retail billionaire Leslie Wexner; billionaire investor Leon Black; Epstein’s onetime attorney Alan Dershowitz; and Jean-Luc Brunel, a French modeling scout who died in 2022 by suicide in a French jail cell after being charged with raping teenage girls.

The Washington Post has more, saying ‘attention to Trump’s relationship with Epstein is not going away anytime soon, and the political headaches for the president are likely to linger.’

In a partially redacted photo, Epstein is holding an oversized check made out to him for $22,500 with DJTRUMP on the signature line. The handwritten caption: ‘Sells ‘fully depreciated’ [redacted] to Donald Trump for $22,500.’ 

Trump allies have decided to make their stand on the signature question, adding to the murkiness.

‘Is this really the best they could do?’ wrote MAGA influencer Benny Johnson. ‘Trump has the most famous signature in the world. Time to sue them into the oblivion.’

In a drawing, labeled ‘1983,’ a male figure is pictured handing balloons to young girls in pigtails. That was next to ‘2003,’ where he’s drawn getting massages from topless blonde women with the caption ‘what a great country!’

Look, there’s no other way to say it: This has the whiff of a cover-up.

I mean, are people buying the president’s insistence that he never sent the birthday message that they’ve seen with their own eyes?

Trump boxed himself by insisting, even now, that he’d never sent such a message. That’s the heart of the political problem.

The president may pronounce the story dead, but for the rest of the world – including MAGA supporters who have been obsessed with this case – it’s very much alive.

This post appeared first on FOX NEWS

Business tycoon Elon Musk agreed with Vice President JD Vance’s assertion that the bulk of violent crime is perpetrated by a small pool of people who should be locked up.

‘The big lie the Democrats told about violent crime is that it’s ‘systemic’ and therefore no one’s really responsible. If the ‘system’ is to blame then you fund a bunch of nonprofits that don’t do anything besides give jobs to underqualified radicals,’ Vance noted in a post on X. ‘The reality is that the gross majority of violent crime is committed by a very small group of people and we should be throwing them in prison.’

Musk agreed, saying that people who have greater sympathy for those likely to perpetrate murder than for those at risk of becoming murder victims are ‘disgusting.’

‘Yes,’ he commented when sharing Vance’s post. ‘What it comes down to is this: Do you have more sympathy for those highly likely to commit murder or more for those at risk of being murdered? If the former, you are a disgusting human being and yet so many on the radical left choose this!’

Republican Rep. Beth Van Duyne of Texas also shared Vance’s post.

‘The crime and homeless industrial complexes Democrats have set up with NGOs and nonprofits’ aren’t designed to solve problems,’ the congresswoman asserted. ‘Rather, they are fraudulent entities which exist to launder taxpayer dollars to enrich themselves, their friends, and further radical, pro-criminal policies that only endanger hard working Americans.’

Musk has also advocated for locking up repeat violent criminals for life.

‘A second conviction for aggravated violent crime should get life imprisonment,’ he wrote on X.

This post appeared first on FOX NEWS

House Republicans are having early talks about cracking down on crime nationwide, the No. 2 GOP lawmaker suggested on Tuesday.

‘There are discussions about addressing some of these problems at a more federal level, but right now, we’re focused on D.C.,’ House Majority Leader Steve Scalise, R-La., told Fox News Digital.

‘The president’s been very effectively reducing crime in D.C., and he’s got some limitations right now with a lot of these ordinances, and that’s what we’re focused on cleaning up.’

He added, however, ‘But we’re not done.’

It comes after President Donald Trump federalized the Washington, D.C., police force and deployed federal troops to the capital city in a bid to end violent crime. He’s now eyeing National Guard deployments in other cities across the country, though the idea has been met with criticism by Democrats.

The House Oversight Committee is slated to advance several bills dealing with D.C. criminal sentencing this week, which will likely get full House votes in the coming months.

Scalise’s comments suggest that while lawmakers are currently focused on overhauling Washington, D.C.’s criminal policies, it’s possible they could turn to the rest of the country at some point as well.

Trump similarly signaled last month that he wanted to see a bill dealing with crime across the U.S.

‘Speaker Mike Johnson, and Leader John Thune, are working with me, and other Republicans, on a Comprehensive Crime Bill. It’s what our Country needs,’ he wrote on Truth Social.

House GOP leaders also railed against crime in Democrat-run cities and states during their weekly press briefing on Tuesday – specifically their leaders’ opposition to National Guard deployments.

Such moves by the federal government could risk court battles with Democrat-run states and cities, as was the case when Trump sent the National Guard into Los Angeles earlier this year over the objections of California Gov. Gavin Newsom.

‘I mean, these mayors in these big blue cities have to ask this question – and I think their voters and the residents and the law-abiding citizens in all these cities should be asking local leadership, ‘How long are you going to put up with this? When are you going to put your foot down and do the right thing?’’ Speaker Mike Johnson, R-La., posed.

‘This is common sense. And I cannot, for the life of me, understand how the Democrats think this is some sort of winning political message. Yield, man. Let the troops come into your city, and show how crime can be reduced.’

Scalise, meanwhile, said at the press conference that Democrats ‘want crime to continue.’

‘They want to continue defunding the police and try to have it both ways. And President Trump is tired of that game, because he’s tired of watching people be hurt. There’s no reason for this violent crime wave that we see in so many cities,’ Scalise said. 

‘So we’re going to continue to have the president’s back and, frankly, have the American people’s back, regardless of their party, regardless of what city they live in. Everybody deserves to be safe, and Republicans are going to continue to push policies to help put that in place.’

This post appeared first on FOX NEWS

Former Vice President Kamala Harris admits that former President Joe Biden got ‘tired’ while in office, but she insists there was no ‘big conspiracy’ to cover up his decline.

Harris made the claims in a newly released excerpt from her upcoming book, ‘107 Days,’ which details her experience running for president with frequent throwbacks to her time as number two in the White House. The excerpt, published by The Atlantic, focuses on her relationship with Biden and her frustration with how she was treated in the Biden-Harris administration.

‘Many people want to spin up a narrative of some big conspiracy at the White House to hide Joe Biden’s infirmity. Here is the truth as I lived it. Joe Biden was a smart guy with long experience and deep conviction, able to discharge the duties of president,’ Harris wrote. ‘On his worst day, he was more deeply knowledgeable, more capable of exercising judgment, and far more compassionate than Donald Trump on his best. But at 81, Joe got tired.’

‘That’s when his age showed in physical and verbal stumbles. I don’t think it’s any surprise that the debate debacle happened right after two back-to-back trips to Europe and a flight to the West Coast for a Hollywood fundraiser. I don’t believe it was incapacity. If I believed that, I would have said so. As loyal as I am to President Biden, I am more loyal to my country,’ she added.

Harris went on to complain that Biden’s staff didn’t give her the support she felt was necessary as vice president, on issues from foreign policy to illegal immigration.

She complained that getting the White House press office, including then-press secretary Karine Jean-Pierre, to defend her was ‘almost impossible.’

‘Worse, I often learned that the president’s staff was adding fuel to negative narratives that sprang up around me. One narrative that took a stubborn hold was that I had a ‘chaotic’ office and unusually high staff turnover during my first year,’ Harris wrote, going on to say that some people just can’t hack it in a White House role.

‘Their thinking was zero-sum: If she’s shining, he’s dimmed. None of them grasped that if I did well, he did well,’  she added regarding Biden’s staff. ‘That given the concerns about his age, my visible success as his vice president was vital. It would serve as a testament to his judgment in choosing me and reassurance that if something happened, the country was in good hands. My success was important for him.

The former vice president also said Democrats across the board should have been more aggressive in pushing Biden not to run, saying it was ‘reckless’ to leave the decision in his hands for so long.

”It’s Joe and Jill’s decision.’ We all said that, like a mantra, as if we’d all been hypnotized. Was it grace, or was it recklessness? In retrospect, I think it was recklessness. The stakes were simply too high. This wasn’t a choice that should have been left to an individual’s ego, an individual’s ambition. It should have been more than a personal decision,’ Harris wrote.

This post appeared first on FOX NEWS

Sen. Steve Daines, R-Mont., is traveling to Israel following the Jewish state’s strike in Qatar, a strike he argued was part of Israel’s ‘singular purpose’ to eradicate Hamas.

The Israel Defense Force (IDF) announced the strike, which was intended to target senior-level leadership in Hamas, on Tuesday. However, the attack took place over 1,300 miles away in Doha, Qatar.

The Qatari government has been a key player at the negotiation table in the quest for a ceasefire and return of hostages in the ongoing conflict between Israel and the terrorist organization Hamas following the group’s brutal attack on Oct. 7, 2023. Israel’s targets were top negotiators in Hamas’ political bureau, who were mulling the latest U.S. ceasefire proposal.

So far, Qatari officials have condemned the strike, and the White House has taken a rare step against Israel in the aftermath.

Daines, who is a member of the Senate Foreign Relations Committee, likened Hamas to ‘a cancer’ that Israel needed to eradicate. He put the Jewish state’s situation into perspective of, if the U.S. were in Israel’s position and ‘1,200 innocent Americans [were] slaughtered by terrorists 40 miles from Washington, D.C.,’ then the ‘United States would do everything within its power to eradicate the threat.’

‘The Israelis, as we’ve seen, whether it’s with Iran or Hezbollah, sometimes doesn’t matter where these leaders are,’ he told Fox News Digital. ‘They’re going to come after them, not unlike the United States did when we went after Usama bin Laden in Pakistan. We didn’t ask Pakistan for permission.’

Following the attack, President Donald Trump told reporters that he was ‘not thrilled’ about the situation.

‘I was very unhappy about it, very unhappy about every aspect. And we got to get the hostages back, but I was very unhappy about the way that went down,’ Trump said.

The Qatari Foreign Ministry condemned the attack and panned Israel’s move as a ‘criminal attack’ that constituted ‘a flagrant violation of all international laws and norms and a serious threat to the security and safety of Qataris and residents of Qatar.’

Daines’ plan to head to the Jewish state came before the strike and was initially meant to celebrate the excavation of ancient stone steps and a pathway, known as the Pilgrimage Road, which Jesus is believed to have walked, leading from the Pool of Siloam to the Temple Mount.

The lawmaker previously went to Israel to commemorate progress of the ongoing archaeological dig in 2023, a couple of months before Hamas’ blitz on Israel.

Now, his planned trip, where Secretary of State Marco Rubio and U.S. Ambassador to Israel Mike Huckabee are expected to attend, is likely to take a different tenor.

Daines said he had just spoken with the Israeli Ambassador to the U.S. on Monday and hoped that his schedule could line up for a meeting with Israeli Prime Minister Benjamin Netanyahu. He also noted that he had yet to see an assessment of the strike, which hit a residential complex in Doha.

When asked if he was worried that the strike could derail ceasefire talks, Daines noted that he had appreciated Qatar’s cooperation and pointed out the U.S. has its largest military base in the Middle East there. But, he added that ‘Hamas, clearly, is trying to evade the reach of the Israeli government.’

‘And as we say, ‘Sometimes you can run, but you can’t hide,’ and Israel had to make a decision, knowing that, like they did with Iran, where they took out military leadership, they took out their nuclear scientists, because they could not allow Iran to get into their bomb,’ Daines said.

‘Similarly, with Hamas, they would have to take out their command and control structure, leadership. And they have a singular mission, and Israel will do what it needs to do to protect herself,’ he continued.

Fox News Digital reached out to the State Department for comment but did not immediately hear back. 

Fox News’ Greg Norman contributed to this report. 

This post appeared first on FOX NEWS

President Donald Trump called for Decarlos Brown Jr. to face the death penalty for the alleged murder of Iryna Zarutska on Wednesday.

Trump made the statement on social media, saying the trial for suspect Decarlos Brown Jr. should be ‘quick.’ 

‘The ANIMAL who so violently killed the beautiful young lady from Ukraine, who came to America searching for peace and safety, should be given a ‘Quick’ (there is no doubt!) Trial, and only awarded THE DEATH PENALTY,’ Trump posted on Truth Social. ‘There can be no other option!’

Zarutska’s slaying has brought about heavy criticism of Democrats, who critics accuse of adopting soft-on-crime laws that allow violent criminals to roam the streets. Trump argued Monday that the victim’s ‘blood is on the hands of the Democrats who refuse to put bad people in jail.’

Trump also placed blame for Zarutska’s killing on former Democratic Gov. Roy Cooper, who is now running for the Senate in battleground North Carolina in a crucial 2026 showdown that may determine if Republicans keep control of the chamber.

The Charlotte killing came amid Trump’s focus this summer on spotlighting horrific crimes in Democrat-controlled cities as he moves federal law enforcement into urban areas.

Brown, who is Black, was arrested soon after the stabbing and charged with first-degree murder. On Tuesday, the Department of Justice charged Brown with one count of committing an act causing death on a mass transportation system.

Records obtained by Fox News Digital showed that Brown has a history of arrests going back more than a decade, including convictions for felony larceny and felony breaking and entering in 2013, and a 2015 conviction for robbery with a dangerous weapon that sent him to prison for more than six years. He was released in 2020 but remained on parole until 2021, and subsequent charges against him included communicating threats and misuse of the 911 system earlier this year.

On Monday, Trump noted other recent killings in the U.S., saying that actions, like his administration’s push to end cashless bail, must be taken.

‘This cashless bail started a wave in our country where a killer kills somebody and is out on the street by the afternoon and, in many cases, going out and killing again, cashless bail,’ Trump said.

Fox News’ Paul Steinhauser and Stephen Sorace contributed to this report

This post appeared first on FOX NEWS

Jury selection is expected to wrap up Wednesday in the federal trial of Ryan Routh, the 59-year-old North Carolina man accused of attempting to assassinate President Donald Trump last year. 

The court is working through its third and final panel of prospective jurors, aiming to seat 12 jurors and four alternates before opening statements begin Thursday morning.

By the end of Tuesday, the court had already dismissed more than 70 of the initial 180 prospective jurors, many citing strong opinions about Trump, connections to law enforcement, or concerns about impartiality in a highly politicized case. 

All eyes will be on how quickly the court can seat a full panel and whether Routh continues to test the boundaries of self-representation. Trump-appointee Judge Aileen Cannon, who is presiding over the case, repeatedly clashed with the defendant as she struck down a list of off-topic and politically charged questions Routh posed to prospective jurors during selection.

Routh inquired how potential jurors felt about Ukraine and the war in Gaza and threw in an oddball question about how they might react to finding a turtle in the road, prompting Cannon to remind him that ‘pro se’ status does not excuse him from courtroom procedure. His adult children were present in court, with one son, Oran, listed as a character witness despite currently being jailed on unrelated charges.

Routh also attempted to strike a potential juror who revealed he had once had breakfast with the president and first lady while interviewing for a golf course superintendent job 25 years ago. The man told the court he respected Trump and found him ‘very nice,’ but insisted he could still be fair. Cannon denied Routh’s request, noting the decades-old interaction did not disqualify him.

Tuesday also saw Cannon remove 23 jurors from a third pool of 60, leaving a pool of roughly 110 prospective jurors still under consideration. Among those dismissed earlier were a man who said he was present at Routh’s arrest, another who received a voicemail from him two days before, and a woman who stood up during questioning to declare, ‘I am MAGA… This is our president,’ before admitting she could not presume Routh’s innocence.

Routh himself moved to have a juror excused for racist comments in a questionnaire, which the court granted.

Routh has pleaded not guilty to federal charges of attempting to assassinate a major presidential candidate and assaulting a federal officer. Prosecutors say he was armed with an AK-style rifle when Secret Service agents stopped him near Trump’s golf course in West Palm Beach in September 2024.

Opening statements are tentatively scheduled for Thursday, Sept. 11, if the panel is seated on time.

The trial is expected to last several weeks, but Cannon urged both sides to keep proceedings efficient.

This post appeared first on FOX NEWS

The Toronto Stock Exchange (TSX) has released its annual TSX30 list, showcasing the 30 top-performing companies that are making the most impact in driving Canada’s economy forward.

Established in 2019, the TSX30 ranks stocks by their dividend-adjusted share price performance over three years.

The list was released on Tuesday (September 9), a day after the S&P/TSX Composite Index (INDEXTSI:OSPTX) reached an all-time high of 29,027. It’s up 17.18 percent since the start of the year and nearly 30 percent since September 2024.

Mining stocks have helped drive these gains, and companies in the sector claimed 17 spots on this year’s TSX30 list. Gold and silver miners dominated, accounting for 15 of the 17 resource sector stocks on the list.

The top-ranked precious metals producer was Lundin Gold (TSX:LUG,OTCQX:LUGDF), which took second place overall on the list, recording a 775 percent share price gain over the past three years.

Its surge has largely been driven by increasing output at its Fruta del Norte operation in Ecuador. According to Mining Data Online (MDO), its gold output came in at 502,000 ounces in 2024 and is projected at 475,000 to 525,000 ounces in 2025.

At number five was Avino Silver & Gold Mines (TSX:ASM,NYSEAMERICAN:ASM), which has gained 610 percent over the past three years. Silver production at its namesake mine in Durango, Mexico, reached a record 1.11 million ounces in 2024. In December 2024, the firm started development work at its La Preciosa project, also in Durango.

Since the start of the year, Avino’s share price has increased by more than 350 percent.

At number 11 is New Gold (TSX:NGD,NYSEAMERICAN:NGD), a mid-tier producer with two gold mines located in BC and Ontario. According to MDO, its Rainy River mine in Southwest Ontario recorded gold output of 226,000 ounces in 2024, while new Ashton increased its production to 72,000 ounces, up from 63,000 ounces in 2023 and 38,000 ounces in 2022.

The company beat its low-end guidance for all-in sustaining costs in 2024 at US$1,239.

The remaining precious metals-focused companies on the TSX30 list are: Kinross Gold (TSX:K,NYSE:KGC) (12), IAMGOLD (TSX:IMG,NYSE:IAG) (13), Torex Gold Resources (TSX:TXG,OTCQX:TORXF) (14), Alamos Gold (TSX:AGI,NYSE:AGI) (19), Perpetua Resources (TSX:PPTA,NASDAQ:PPTA) (21), Orla Mining (TSX:OLA,NYSEAMERICAN:ORLA) (22), China Gold International Resources (TSX:CGG) (25), Dundee Precious Metals (TSX:DPM) (26), Eldorado Gold (TSX:ELD,NYSE:EGO) (27), Galiano Gold (TSX:GAU,NYSEAMERICAN:GAU) (28), Skeena Resources (TSX:SKE,NYSE:SKE) (29) and Taseko Mines (TSX:TKO,NYSEAMERICAN:TGB) (30).

The non-gold resource companies listed are Almonty Industries (TSX:AII,NASDAQ:ALM) (10) and Cameco (TSX:CCO,NYSE:CCJ) (23). In the top spot overall was Celestica (TSX:CLS,NYSE:CLS), which provides artificial intelligence-powered supply chain optimization solutions. Over the past three years, its share price has gained 1,599 percent.

Gold and silver producers have fared well in 2025 as uncertainty bleeds into the global economy on the back of shifting US trade policies. This has prompted many investors to turn to the safety and stability of precious metals.

Gold has risen to record highs above US$3,600 per ounce in recent days, while silver is trading above US$40 per ounce.

Securities Disclosure: I, Dean Belder, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.

This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and prevention of diseases and physical conditions, and it continues to develop rapidly.

Examples of medical devices include neurostimulation devices, surgical implants, ultrasound imaging devices and robotic medical technology, along with insulin pumps and insulin pens for diabetes. Just as pharmaceutical companies seek to serve unmet needs, medical device companies do the same via innovative technologies.

In this article

    What should investors know about the medical device market?

    Before investing in medical device stocks, it helps to understand their goals. Medtech companies will often seek to show investors that their products are ready to enter the market and will be in demand right away — whether it be by serving a large demographic or by targeting a specific ailment in the population that has an unmet medical need.

    Like firms pursuing drug approvals, medical device companies must conduct clinical trials to bring their products to market; they have to refine their technology and confirm efficacy and safety to get regulatory approvals.

    Successfully completed clinical trials and product approvals are usually major catalysts for a company’s share price. A medical device stock can experience a large jump when announcing positive results from a recent trial or approval from a regulatory body such as Health Canada, the US Food and Drug Administration (FDA) or an equivalent agency in Europe or Asia. On the other hand, poor results can have a negative impact on the company’s performance.

    Patentability also plays a big role in a medical device company’s value. Once a product has been patented, the company controls its every move and can choose to license it or make other deals to expand device reach.

    What is the outlook for the medical device market?

    The medical device market is expected to experience growth in global annual sales of over 5 percent each year to reach nearly US$800 billion by 2030, according to a forecast from KPMG.

    Driving that growth will be an increase in demand for new devices like wearables and services like health data, alongside diseases, particularly cancer and diabetes, plus cardiovascular, neurological, orthopedic and respiratory diseases, which are on the rise due to an aging population.

    Chronic diseases are also growing in prevalence. The United Nations has said that by the end of 2050, the ratio of deaths per year due to chronic diseases is expected to rise to around 86 percent of total deaths each year.

    KPMG sees the adoption of five key technologies, what it calls ‘patient and consumer data sharing technologies,’ as critical for ‘winning companies in 2030.’ These are wearables, smart device apps, Internet of Things (IoT), cloud-based data and analytics, and blockchain.

    The top five geographical markets identified by the firm are the United States, China, France, Germany and India.

    In short, with the future growth of the market expected to be robust, there are many opportunities for investing in the medical device industry.

    How to invest in medical device stocks

    Large-cap medical device stocks

    The sector is dominated by a handful of big medical device manufacturers, which means investors interested in large-cap companies will have no trouble finding what they’re looking for. Here are a few to get you started:

    Abbott Laboratories (NYSE:ABT)
    Abbott Laboratories creates a wide range of products, from diagnostics to medical devices to branded generic pharmaceuticals. Its medical devices focus on segments including vascular diseases, diabetes and optometry.

    Intuitive Surgical (NASDAQ:ISRG)
    Medical device manufacturer Intuitive Surgical developed the da Vinci surgical system, the first minimally invasive surgical system to receive clearance from the US FDA. The company’s goal is to provide assistance to doctors and hospitals with its robotics-assisted platforms, including the da Vinci system.

    Medtronic (NYSE:MDT)
    Medtronic’s devices provide solutions for relieving pain, restoring health and working to extend the lives of millions of people globally. Its primary areas of focus include cardiac and vascular care, minimally invasive therapies, restorative therapies and diabetes.

    Danaher (NYSE:DHR)
    Globally diversified conglomerate Danaher has a number of brands under its corporate umbrella grouped in three distinct divisions: healthcare, diagnostics and environmental and applied end markets. Through its brands, Danaher designs, manufactures and sells a number of medical device products and services.

    Thermo Fisher Scientific (NYSE:TMO)
    Thermo Fisher Scientific’s family of global products and services represents a broad range of high-end analytical instruments, chemistry and consumable supplies, laboratory equipment and software. It has products in a variety of areas, including cellular analysis, synthetic biology and molecular biology.

    Small-cap medical device stocks

    Investors will also find smaller-cap medical device companies amid the heavyweights — it’s just a matter of risk tolerance. Below are five great examples.

    AngioDynamics (NASDAQ:ANGO)
    AngioDynamics is a global medical technology company that designs, manufacturers and sells high-quality, minimally invasive medical devices. Its devices target vascular access procedures and treatment of peripheral vascular and oncological diseases.

    Aurora Spine (TSXV:ASG,OTCQB:ASAPF)
    Aurora Spine is a Canadian medical device company focused on the spinal implant market. It has a portfolio of minimally invasive, regenerative spinal implant technologies designed to improve spinal surgery outcomes. Its FDA-approved products include the DEXA patient-matched implant technology and the ZIP series of implants for lumbar spinal stenosis.

    Delcath Systems (NASDAQ:DCTH)
    Delcath Systems is a pharmaceutical and medical device company focused on “interventional oncology,” specifically regarding the treatment of primary and metastatic liver cancers. The company’s commercial products combine its Hepactic Delivery System with the chemotherapeutic drug melphalan for to help liver cancer patients undergo safer high-dose chemotherapy.

    Senseonics (NYSEAMERICAN:SENS)
    Senseonics is a commercial-stage medical technology company that develops and manufactures continuous glucose monitoring systems for people with diabetes. The company’s Eversense 365 and Eversense E3 systems are long-term, implantable devices that use sensor technology to transmit frequent glucose data updates via a smartphone app.

    iRhythm Technologies (NASDAQ:IRTC)
    iRhythm Technologies’ wearable biosensor device, the Zio ECG monitor, is used for the diagnosis of cardiac arrhythmias. The FDA-cleared device uses AI and a clinically proven deep-learned algorithm to enable accurate diagnoses.

    How to invest in medical device ETFs

    For those who prefer to mitigate risk, exchange-traded funds (ETFs) are a safer way to put money into the market, and there are two primary medical device ETFs for investors to choose from.

    ETFs hold assets such as stocks, commodities and bonds, and trade close to their net asset value. With exposure to various companies, any potential decrease in one stock won’t significantly drive down overall ETF returns.

    Typically ETFs track an index. In the medical device arena, there are two indexes that can be followed: the S&P Health Care Equipment Select Industry Index (INDEXSP:SPSIHE) and the Dow Jones US Select Medical Equipment Index (INDEXDJX:DJSMDQ).

    Below are the two biggest medical device ETFs:

    iShares US Medical Devices ETF (ARCA:IHI)
    The iShares US Medical Device ETF is the largest ETF in the medical device sector. Its focus is on US companies that manufacture and distribute medical devices. This passive ETF tracks the Dow Jones US Select Medical Equipment Index. Three of its top holdings are Abbott Laboratories, Intuitive Surgical and Boston Scientific (NYSE:BSX).

    SPDR S&P Health Care Equipment ETF (ARCA:XHE)
    The SPDR S&P Health Care Equipment ETF tracks the S&P Health Care Equipment Select Industry Index. Its top holdings include Staar Surgical (NASDAQ:STAA), ResMed (NYSE:RMD) and iRhythm Technologies.

    Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

    This post appeared first on investingnews.com

    Perth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) is pleased to advise it has moved to secure additional beneficiated ore supply to complement development of its Desert Antimony Mine at Mojave, California. This initiative forms part of the Company’s broader mine to market strategy targeting supply for the U.S. defense and energy markets, while also strengthening the commercial pathway for its DeepSolv(TM) processing technology being developed with Rice University.

    Highlights

    – Locksley seeks to strengthen the commercial pathways for DeepSolv(TM) processing method, by entered into a Non-Binding Heads of Agreement with EV Resources Limited (EVR) to purchase EVR’s Antimony material via an Ore Sales Agreement

    – Availability of 3rd party material is a key element for the development of DeepSolv(TM) and access to the USD $1bn+ domestic US Antimony market

    – Expands and diversifies ore feedstock available for the processing development and downstream validation being conducted by Rice University on the DeepSolv(TM) product

    – Enables Locksley to integrate both domestic ore from Mojave and additional North American supply into U.S. refining, accelerating the availability of critical materials

    – Access to multiple ore supplies is complementary to the development of the Desert Antimony Mine at Mojave and advances Locksley’s strategy of providing domestic security of USA antimony supply necessary for defence security

    – Will provide priority access to antimony samples from EV Resources’ Los Lirios operations for Rice University DeepSolv(TM) testwork, promoting a diversified and resilient North American supply chain

    – Contingent on Locksley and EVR successfully negotiating a binding Antimony Ore Sales Agreement and subject to EVR shareholder approval, Locksley will make a strategic investment of A$0.75 million in EV Resources Limited (ASX:EVR)

    Strategic Rationale: DeepSolv(TM) Processing Pathway

    The securing of EVR beneficiated ore will underpin Locksley’s ability to accelerate deployment of DeepSolv(TM), a proprietary solvometallurgical process developed with Rice University, by ensuring additional steady and diverse feedstock supply. This strengthens the Company’s position to:

    – Provide immediate beneficiated ore supply to complement Mojave ore and bridge U.S. requirements until domestic mining commences

    – Validate the DeepSolv(TM) process across multiple ore types, ensuring resilience and efficiency in downstream refining

    – Secure 3rd party material as a key element for establishing the scale of DeepSolv(TM) and access to the USD $1bn+ domestic US Antimony market

    – Advance production of defense-grade and energy-grade antimony products for U.S. applications

    – Demonstrate to U.S. Government stakeholders the practical delivery of non-Chinese feedstock through advanced U.S.-based processing

    – Position Locksley as a leading partner in reshaping North American supply chains for critical minerals

    Strategic Locksley Investment and Ore Sales Agreement

    LKY and EVR have entered into a non-binding Heads of Agreement. Contingent upon LKY and EVR entering into a binding Ore Sales Agreement, and subject to EVR shareholder approval,

    LKY will make a strategic investment of A$0.75 million. This agreement provides a framework for EVR to supply antimony concentrate from its Los Lirios operations to Locksley, with the following key points:

    – Purpose: The Agreement sets out the non-binding commercial framework under which EVR and LKY will cooperate to establish a strategic relationship for material testwork and develop production and value creation.

    – Testing and Validation: EVR will send representative samples of ore to Locksley’s refining facility to test and confirm ore properties and processing viability.

    – Pathway to Binding Agreement: The parties will seek to enter into a binding Ore Sales Agreement which will set out the commercial framework for a long-term supply partnership, with an initial focus on offtake to support downstream processing studies.

    – Mutual Strategic Benefit: The cooperation secures a potential long-term customer for EVR’s concentrate while reinforcing Locksley’s access to a secure supply of antimony for its proprietary refining technology.

    Pat Burke, Chairman of Locksley Resources, commented:

    ‘This agreement potentially strengthens our mine-to-market strategy by complementing our Mojave development with additional concentrate supply from EVR. By securing nearshore feedstock alongside our fast-tracked mining plans in California, Locksley will be well positioned to accelerate the U.S. return to domestic antimony processing. With Rice University’s support and the deployment of our DeepSolv(TM) technology, our pathway demonstrates that Locksley is assembling the resources, partnerships, and technology to ensure secure, scalable, and independent antimony supply for the United States.’

    About Locksley Resources Limited:

    Locksley Resources Limited (ASX:LKY,OTC:LKYRF) (OTCMKTS:LKYRF) (FRA:X5L) is an ASX-listed explorer focused on critical minerals in the United States of America. The Company is actively advancing exploration across the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley Resources aims to generate shareholder value through strategic exploration, discovery and development of critical minerals for U.S.

    Mojave Project

    Located in the Mojave Desert, California, the Mojave Project comprises over 240 claims across two contiguous prospect areas, namely, the North Block-Northeast Block and the El Campo Prospect. The North Block directly abuts claims held by MP Materials, while El Campo lies along strike of the Mountain Pass Mine and is enveloped by MP Materials’ claims, highlighting the strong geological continuity and exploration potential of the project area.

    In addition to rare earths, the Mojave Project hosts the historic ‘Desert Antimony Mine’, which last operated in 1937. Despite the United States currently having no domestic antimony production, demand for the metal remains high due to its essential role in defense systems, semiconductors, and metal alloys. With surface samples grading up to 46% Sb as well as silver up to 1,022 g/t Ag, the Desert Mine prospect represents one of the highest-grade known antimony occurrences in the U.S.

    Locksley’s North American position is further strengthened by rising geopolitical urgency to diversify supply chains away from China, the global leader in both REE & antimony production. With its maiden drilling program planned, the Mojave Project is uniquely positioned to align with U.S. strategic objectives around critical mineral independence and economic security.

    Source:
    Locksley Resources Limited

    Contact:
    Locksley Resources Limited
    T: +61 8 9481 0389
    E: info@locksleyresources.com.au

    News Provided by ABN Newswire via QuoteMedia

    This post appeared first on investingnews.com